SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-22-000101
Filing Date
2022-11-09
Accepted
2022-11-09 16:05:15
Documents
95
Period of Report
2022-10-02

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20221002.htm   iXBRL 10-Q 3929563
2 EX-31.1 pfe-exh311x1002202210q.htm EX-31.1 9180
3 EX-31.2 pfe-exh312x1002202210q.htm EX-31.2 9172
4 EX-32.1 pfe-exh321x1002202210q.htm EX-32.1 4617
5 EX-32.2 pfe-exh322x1002202210q.htm EX-32.2 4598
  Complete submission text file 0000078003-22-000101.txt   17019289

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20221002.xsd EX-101.SCH 89895
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20221002_cal.xml EX-101.CAL 160323
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20221002_def.xml EX-101.DEF 489325
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20221002_lab.xml EX-101.LAB 982021
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20221002_pre.xml EX-101.PRE 676709
89 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20221002_htm.xml XML 4341059
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 221372495
SIC: 2834 Pharmaceutical Preparations